Related Experiment Video
Updated: Aug 28, 2026

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
Evidence for a receptor supersensitivity following impairment of central serotoninergic activity in the rabbit
Abstract:
In order to investigate whether a chronic impairment of neuronal serotoninergic transmission in the CNS could result in a receptor supersensitivity, rabbits were pretreated either with 5,6-dihydroxytryptamine (5,6-DHT) or p-chlorophenylalanine (PCPA) and then tested for their hyperthermic response to serotoninergic agonists. A previous (10 days before) intracerebroventricular injection of 5,6-DHT (75 microgram into each cerebral ventricle) significantly potentiated the increase in body temperature induced either by quipazine (1 mg/kg i.v.) or by 5-hydroxytryptophan (5-HTP 2 mg/kg i.v.) in combination with a MAO inhibitor (phenylethylhydrazine 10 mg/kg i.v. 16 h before). Pretreatment with PCPA (100 mg/kg s.c. four times on alternate days, the last dose 48 h before the experiment) also enhanced the hyperthermic effect of quipazine, whereas it inhibited the hyperthermic response to 5-HTP plus MAO inhibitor. These results suggest the existence of a receptor supersensitivity following prolonged blockade of serotoninergic neuronal transmission in the CNS.
Insights
Chronic impairment of central nervous system (CNS) serotoninergic transmission may lead to receptor supersensitivity. This study in rabbits suggests that prolonged blockade of this system can indeed cause such changes.
Area of Science:
- Neuroscience
- Pharmacology
- Physiology
Background:
- Serotoninergic transmission plays a crucial role in CNS functions.
- Understanding receptor sensitivity is vital for neurological drug development.
Purpose of the Study:
- To investigate if chronic impairment of CNS serotoninergic transmission leads to receptor supersensitivity.
- To examine the hyperthermic responses to serotoninergic agonists after neuronal blockade.
Main Methods:
- Rabbits were pretreated with 5,6-dihydroxytryptamine (5,6-DHT) or p-chlorophenylalanine (PCPA) to impair serotoninergic transmission.
- Hyperthermic responses to quipazine and 5-hydroxytryptophan (5-HTP) with a MAO inhibitor were measured.
Main Results:
- 5,6-DHT pretreatment potentiated hyperthermia induced by quipazine and 5-HTP (plus MAO inhibitor).
- PCPA pretreatment enhanced quipazine-induced hyperthermia but inhibited the response to 5-HTP (plus MAO inhibitor).
Conclusions:
- Results suggest receptor supersensitivity following prolonged blockade of CNS serotoninergic neuronal transmission.
- Differential effects indicate complex regulatory mechanisms within the serotoninergic system.
More Related Videos
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
10:25Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
Published on: March 27, 2021